EP Lab

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic embolism (SE) in patients with...

DAIC readers chose the following stories as the most popular content in 2014, based on website analytics. The list is broken into the top 20 most popular news items from 2014 and a list of the top 20 archived technical articles accessed in 2014....

Accolade pacemaker, Ingevity leads,

Boston Scientific Corp. has received CE mark approval for the Accolade pacemaker family. 

Medtronic Inc. announced the U.S. launch of the SEEQ Mobile Cardiac Telemetry (MCT) System, an external, wire-free, adhesive heart monitor that can be worn for up to 30 days to help detect and diagnose the cause of irregular heartbeats in patients...

ECRI Institute has released an updated comparison on cardiac resuscitators used during cardiopulmonary resuscitation (CPR).
FEops, TAVIguide, Series A financing, navigation, advanced visualization
FEops announced the closing of a €1.3 million (~$1.9 million USD) series A financing round, led by Capricorn Venture Partners and PMV. The funding will be used...
St. Jude, STAR-VT, ventricular tachycardia, ablation catheter, FlexAbility
St. Jude Medical Inc. announced the first patient enrollment in the STAR-VT (Substrate Targeted Ablation using the FlexAbility Ablation Catheter...
Clinical trial/study, EP Lab, WRAP Infection Clinical Trial
Medtronic Inc. announced the first patient enrollment in the WRAP Infection Clinical Trial, which will evaluate the effectiveness of the TYRX Absorbable...
CVRx, Barostim neo Legacy System, pacemaker, hypertension, FDA, HDE
The U.S. Food and Drug Administration (FDA) has granted a humanitarian device exemption for the CVRx Inc. Barostim neo Legacy System. The
Savaysa (edoxaban) tablets from Daiichi Sankyo Co. Ltd. are an oral, once-daily selective factor Xa-inhibitor to reduce the risk of stroke...
The RadAR vascular compression device from Advanced Vascular Dynamics is specified for post-procedure hemostasis of tibiopedal access...
The third-generation AliveCor Heart Monitor from AliveCor Inc. gives users the ability to identify and manage heart conditions with a U.S....

Articles

ECRI Institute has released an updated comparison on cardiac resuscitators used during cardiopulmonary resuscitation (CPR).
absorb, bioresorbable stents
DAIC readers chose the following stories as the most popular content in 2014, based on website analytics. The list is broken into the top 20 most popular news...
Medtronic, Attain Performa, quadripolar leads
Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV)...
AHA, warfarin, antiplatelet therapy, atrial fibrillation, anti-clotting, EP lab
Long-term overtreatment with the anti-clotting drug warfarin combined with antiplatelet therapy to prevent stroke may raise the risk of dementia in people with...

Video Center

The America College of Cardiology has released its list of key late-breaking clinical trials at the...
6 days 10 hours ago
As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict...
3 weeks 6 days ago
There were a few intriguing technology trends at the Radiological Society of North America (RSNA)...
5 weeks 4 days ago
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...